20th October 2021 | Pharma Updates

India's API space attracts Mergers & Acquistions deals

Good valuations and certified plants make the India’s Active Pharmaceutical Ingredient sector attractive for Indian and global investors.

Pramod Yeole appointed VP of PCI

Pramod Yeole holds a PhD in pharmaceutical sciences and has worked at the Institute of Pharmaceutical Education and Research, Wardha for 15 years.

Aluminium foil shortage may hamper pharma supply chain

Shortage of aluminium foil might lead to scarcity of essential drugs as it is used as a packaging material.

Govt to make Northeast as bio-economic hub

Northeast of India has drawn the attention of Indian Government which has decided to make the region as bio-economic hub.

CDRI make drug for dengue

A Mumbai-based drug firm has received approval from the Drug Controller General of India to conduct clinical trials.

DRL gets approval for Lenalidomide capsules

DRL has received a nod for its Abbreviated New Drug Application Drug, Lenalidomide capsules.

WHO plans to buy Merck's anti;covid drug for USD 10 per pill

Merck’s molnupiravir is a drug to treat patients with mild Covid symptoms.